Catalyst Wire Dossier Catalyst Wire Dossier

Lumbrokinase DLBS1033

lumbrokinase
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lumbrokinase DLBS1033, covering 2025-07-20 to 2025-07-20. Get the full timeline:

Most recent: Clinical Trial Update: Comparing Oral Lumbrokinase DLBS1033 and Betahistine Mesylate in Benign Paroxysmal Positional Vertigo [Phase 4]

See pricing